glp-1 drugs shortage Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s GLP-1 Drug Shortages - Endocrinology

However, renal effects of GLP-1 in heart failure (HF) has not been elucidated

Reddy's Laboratories Limited for manufacturing...

GLP-1 receptor agonist 7 generates cAMP under the mediation of GLP-1R with an EC50 of 0.2 nM

altRx GLP-1 Injections are customized GLP-1 therapy designed for individuals who benefit from a formulation aligned with their specific health goals

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.